The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized multicenter phase II trial to evaluate the safety and efficacy of vaccination with folate receptor alpha (FRα) peptides admixed with GM-CSF as an adjuvant versus GM-CSF alone in patients with platinum-sensitive ovarian cancer (EOC).
 
Roisin Eilish O'Cearbhaill
Consulting or Advisory Role - GlaxoSmithKline; Tesaro
Research Funding - Genmab (Inst); Juno Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Stem CentRx (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
 
Jason A. Konner
Consulting or Advisory Role - Abbvie; Abbvie; AstraZeneca; Immunogen; Tesaro
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Matthew Stephen Block
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Immune Design; Marker, Inc.; Merck; Pharmacyclics
 
James Potts
Consulting or Advisory Role - Veristat (Inst)
 
Gerald Garrett
Employment - Marker Therapeutics
Leadership - Marker Therapeutics
Stock and Other Ownership Interests - Marker Therapeutics
Consulting or Advisory Role - Marker Therapeutics
Travel, Accommodations, Expenses - Marker Therapeutics
 
Richard Kenney
Employment - X-Vax Technology
Leadership - X-VAX Technology
Stock and Other Ownership Interests - Marker Therapeutics; X-Vax Technology
Consulting or Advisory Role - Marker Therapeutics; X-Vax Technology
Travel, Accommodations, Expenses - Marker Therapeutics; X-Vax Technology
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Tesaro
Consulting or Advisory Role - Clovis Oncology; Genentech; Merck; Mersana; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - TapImmune Inc.
Other Relationship - AstraZeneca